Gonadorelin

GnRH analog for fertility preservation and hormonal support

intermediateMid-range

What is Gonadorelin?

Gonadorelin is a synthetic version of gonadotropin-releasing hormone (GnRH), the master regulator of reproductive hormone production. Your hypothalamus naturally releases GnRH in pulses every 60 to 120 minutes. Each pulse signals the anterior pituitary gland to secrete LH and FSH, which then drive testosterone production in the testes and estrogen/progesterone in the ovaries.

The primary clinical use of gonadorelin in the peptide therapy space is fertility preservation for men on testosterone replacement therapy (TRT). Exogenous testosterone shuts down the hypothalamic-pituitary-gonadal (HPG) axis through negative feedback. The pituitary stops producing LH and FSH. Without LH, Leydig cells in the testes stop making testosterone locally. Without FSH, Sertoli cells reduce spermatogenesis. The result: testicular atrophy and potential infertility. Gonadorelin bypasses the suppressed hypothalamus and directly stimulates pituitary LH/FSH release, keeping the downstream machinery active.

Gonadorelin is FDA-approved as a diagnostic tool (Factrel) for evaluating pituitary gonadotroph function. Its therapeutic use for fertility preservation during TRT is off-label but widely practiced in hormone optimization clinics. It has largely replaced hCG for this purpose following FDA regulatory changes that affected compounded hCG availability in 2020.

The peptide is not a direct libido enhancer. It supports the hormonal environment that underlies desire by maintaining LH-driven intratesticular testosterone production. For direct libido enhancement, see PT-141 or Kisspeptin. For a full comparison of peptides that affect sexual function, see Peptides for Libido.

Use the Peptide Interaction Checker to verify compatibility with your current protocol before adding gonadorelin.

How Gonadorelin Works

Gonadorelin acts through a well-defined endocrine signaling cascade:

GnRH Receptor Binding: Gonadorelin binds to GnRH receptors (GnRHR) on gonadotroph cells in the anterior pituitary. These are G-protein coupled receptors that activate phospholipase C, generating inositol trisphosphate (IP3) and diacylglycerol (DAG). IP3 releases intracellular calcium stores, which triggers exocytosis of LH and FSH granules.

Pulsatile vs. Continuous Stimulation: The frequency of GnRH pulses determines which gonadotropin predominates. Fast pulses (every 60 minutes) favor LH secretion. Slow pulses (every 120+ minutes) favor FSH. This is why pulsatile administration of gonadorelin preserves normal physiology, while continuous exposure (as with GnRH agonists like leuprolide) paradoxically desensitizes receptors and suppresses LH/FSH — a process called downregulation.

Downstream Hormonal Effects: LH stimulates Leydig cells in the testes to produce testosterone. FSH stimulates Sertoli cells to support spermatogenesis. In women, LH triggers ovulation and progesterone production from the corpus luteum, while FSH drives follicular development. By maintaining these signals during TRT, gonadorelin prevents the testicular shutdown that exogenous testosterone causes.

Short Half-Life: Gonadorelin has an extremely short plasma half-life of approximately 4 minutes, with a terminal half-life of 10 to 40 minutes. This rapid clearance actually mimics the body's natural pulsatile GnRH release pattern, which is one reason intermittent subcutaneous dosing works well therapeutically.

Benefits of Gonadorelin

Fertility Preservation During TRT This is gonadorelin's primary application. Exogenous testosterone suppresses intratesticular testosterone (ITT) by 94% within weeks, and spermatogenesis declines or ceases entirely in most men. Gonadorelin maintains LH/FSH signaling to preserve both sperm production and testicular volume. A study by Hsieh et al. (2013) confirmed that concurrent GnRH agonist therapy during testosterone administration maintained spermatogenesis parameters compared to testosterone alone (PubMed 23260875). Men who want the benefits of TRT without sacrificing fertility use gonadorelin as standard co-therapy.

Testicular Atrophy Prevention Without LH stimulation, Leydig cells atrophy and testicular volume decreases measurably within months of starting TRT. Gonadorelin prevents this by maintaining LH-driven stimulation. Users consistently report preserved testicular size when gonadorelin is included in their TRT protocol.

Hormonal Diagnostics Gonadorelin is FDA-approved as Factrel for GnRH stimulation testing. A single injection followed by serial LH/FSH blood draws reveals whether the pituitary can respond to GnRH stimulation. This differentiates hypothalamic hypogonadism (pituitary responds) from pituitary hypogonadism (no response). The test guides treatment decisions for men with low testosterone.

Post-Cycle Therapy Support After discontinuing anabolic steroids or exogenous testosterone, the HPG axis needs to restart. Gonadorelin can accelerate recovery by providing pulsatile GnRH stimulation to wake up a suppressed pituitary. It is sometimes combined with selective estrogen receptor modulators (SERMs) like clomiphene for a multi-angle PCT approach.

Indirect Libido Support Gonadorelin does not directly enhance desire the way PT-141 does. However, by maintaining healthy intratesticular testosterone levels and preventing the hormonal crash that accompanies HPG axis shutdown, it supports the endocrine foundation of sexual function. Libido improvements are secondary, gradual, and most noticeable in men whose desire had declined due to low LH/testosterone on TRT.

Side Effects & Safety

Common Side Effects - Injection site redness or irritation (transient) - Mild headache, especially during the first week - Occasional flushing shortly after injection

Less Common Side Effects - Nausea (usually resolves after the first few doses) - Light-headedness - Abdominal discomfort - Skin rash at injection site

Contraindications and Cautions - Gonadorelin is contraindicated in patients with known hypersensitivity to GnRH or any of its analogs. - Women who are pregnant or may become pregnant should not use gonadorelin, as it can affect reproductive hormones unpredictably. - Patients with hormone-sensitive conditions (prostate cancer, breast cancer) should not use gonadorelin without oncologist supervision, as increased LH/FSH could transiently stimulate hormone production. - Continuous high-dose administration can paradoxically suppress LH/FSH through receptor downregulation. Pulsatile dosing is essential. - Patients on GnRH agonists or antagonists for prostate cancer or endometriosis should not add gonadorelin without physician guidance. - Monitor LH, FSH, and testosterone levels every 4 to 8 weeks to confirm the protocol is working and adjust dosing accordingly.

Gonadorelin Dosage Protocols

Protocol	Dose	Frequency	Duration
TRT Fertility Preservation Protocol	100-200 mcg	Subcutaneous, 2-3 times per week	Ongoing (concurrent with TRT)
Post-Cycle Therapy Protocol	100 mcg	Subcutaneous, every other day	4-8 weeks post-cycle
Diagnostic GnRH Stimulation Test	100 mcg	Single intravenous or subcutaneous injection	One-time test

TRT Fertility Preservation Protocol: The most common protocol. Inject subcutaneously in the abdominal area. Timing should mimic pulsatile release — space doses at least 2 days apart. Monitor LH, FSH, and semen analysis every 3-6 months to confirm efficacy. Adjust dose based on bloodwork.

Post-Cycle Therapy Protocol: Begin 1-2 weeks after last testosterone injection (or immediately after short-ester compounds clear). Often combined with a SERM (clomiphene or enclomiphene) for a dual-recovery approach. Taper off as LH/FSH normalize on bloodwork.

Diagnostic GnRH Stimulation Test: Draw baseline LH/FSH. Administer 100 mcg IV or SC. Draw LH/FSH at 15, 30, 45, 60, and 120 minutes post-injection. A normal response shows LH rising 3-6x above baseline. Blunted response suggests pituitary dysfunction.

These are general guidelines for research purposes. Always consult a healthcare professional before use.

Is Gonadorelin Right for You?

Take our quiz to get a personalized recommendation based on your goals and profile.

Start the Quiz

Stacking Gonadorelin

PT-141

Hormonal support plus direct libido enhancement

Gonadorelin at 100-200 mcg 2-3x per week (ongoing, hormonal base) plus PT-141 at 1-2 mg as needed before sexual activity. Gonadorelin maintains the endocrine environment while PT-141 provides acute melanocortin-mediated desire stimulation. The two peptides work through completely independent pathways.

Kisspeptin

Dual HPG axis stimulation for maximum hormonal output

Gonadorelin at 100-200 mcg 2-3x per week plus kisspeptin at 1-5 mcg/kg as directed. Kisspeptin stimulates GnRH neurons upstream, while gonadorelin stimulates the pituitary directly. This dual approach may provide stronger LH/FSH output than either peptide alone. Monitor bloodwork closely to avoid excessive hormonal stimulation.

Frequently Asked Questions

How does gonadorelin compare to hCG for fertility preservation on TRT?

Both maintain testicular function during TRT, but through different mechanisms. hCG mimics LH and directly stimulates Leydig cells. Gonadorelin stimulates the pituitary to produce real LH and FSH, preserving the entire HPG signaling chain. After FDA regulatory changes reduced compounded hCG availability in 2020, many clinics switched to gonadorelin as the primary fertility-preservation tool during TRT. Both are effective; gonadorelin preserves more of the natural hormonal cascade.

Will gonadorelin increase my testosterone levels?

Gonadorelin stimulates LH production, which drives testicular testosterone synthesis. In men with a functioning pituitary and testes, this results in increased intratesticular testosterone. However, if you are already on TRT, the exogenous testosterone is providing your systemic testosterone levels. Gonadorelin's role in that context is preserving local testicular function and fertility, not raising serum testosterone further.

Can gonadorelin be used for libido enhancement?

Not directly. Gonadorelin does not activate desire pathways in the brain. It supports the hormonal foundation (LH, FSH, intratesticular testosterone) that underlies sexual function. If your low libido is caused by HPG axis suppression from TRT, gonadorelin can help by restoring endogenous hormone signaling. For direct desire enhancement, PT-141 is the evidence-based choice. See Peptides for Libido for a full comparison.

Does gonadorelin need to be injected, or can I take it orally?

Gonadorelin must be injected. As a peptide, it would be degraded by digestive enzymes if taken orally. Subcutaneous injection in the abdominal area is standard. The injection is straightforward with an insulin syringe. See How to Reconstitute Peptides for preparation guidance.

What happens if I use gonadorelin continuously instead of pulsatile dosing?

Continuous GnRH exposure desensitizes pituitary GnRH receptors through a process called downregulation. This is actually how GnRH agonists like leuprolide work to suppress hormones in prostate cancer treatment. For fertility preservation, you need pulsatile stimulation — discrete doses spaced apart — to maintain normal LH/FSH secretion patterns. This is why dosing 2-3 times per week works, but daily or continuous infusion would be counterproductive.

Not Sure Which Peptide Protocol Is Right for You?

Take our 2-minute quiz for a personalized recommendation based on your goals and health profile.

Start the Quiz →

Peptides for Libido: Research GuideRead article →Peptide Injections: Complete GuideRead article →How to Reconstitute PeptidesRead article →

References & Clinical Studies

Medical Disclaimer

This content is for informational and educational purposes only. It is not intended as medical advice and should not replace consultation with a qualified healthcare professional. Peptides discussed here may be unapproved for human use in your jurisdiction. Always consult your doctor before starting any new supplement or peptide protocol.